News for Healthier Living

ADC Combination Outperforms Standard Treatment of Advanced Triple-Negative Breast Cancer

Dana-Farber Cancer Institute presents potentially practice changing results from the phase 3 ASCENT-04/KEYNOTE-D19 clinical trial at American Society of Clinical Oncology (ASCO) annual meeting

May 31, 2025


June 7 2025

June 6 2025

June 5 2025

June 4 2025

June 3 2025

June 2 2025

June 1 2025

May 31 2025

May 30 2025

May 29 2025

May 28 2025

May 27 2025

May 26 2025

May 25 2025

May 24 2025